Peptide Libraray

Pep-1

General Information

DCTPep ID DCTPep00945

Peptide Name Pep-1

Sequence KETWWETWWTEWSQPKKKRKV

Sequence Length 21

UniProt ID Not available

PubChem CID Not available

Origin porcine cathelicidin peptide

Type Synthetic peptide

Classification

Cancer therapy related peptides

Activity Information

Cell Line	Disease	Activity	Assay	Testing Time	Literature
Jurkat	Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia	IC50 ≥ 65 µM	MTT assay	24h	1

Hemolytic Activity RBC: IC50 ≥ 65 µM

Normal (non-cancerous) Cytotoxicity PBMC: IC50 ≥ 65 µM

Target Not available

Affinity Not available

Mechanism Not available

Structure Information

PDB ID Not available

Predicted Structure DCTPep00945

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity Not available

Linear/Cyclic Linear

Disulfide/Other Bond Not available

N-terminal Modification Free

C-terminal Modification Cysteamidation

Other Modification None

Chiral L

Physicochemical Information

Formula C136H195N35O33

Absent amino acids ACDFGHILMNY

Theoretical pI 9.82

Acidic residues 3

Basic residues 6

Polar residues 4

Molecular weight (Average) 2848.26

Molecular weight (Monoisotopic) 2846.47

Common amino acids KW

Net charge 3

Instability index (II) 19.89

Aliphatic index 13.81

Grand average of hydropathicity (GRAVY) -2.038

Half Life
1.3 hours (mammalian reticulocytes, in vitro).
3 min (yeast, in vivo).
3 min (Escherichia coli, in vivo).

Extinction coefficients
Ext. coefficient 27500
Abs 0.1% (=1 g/l) 9.655

Amino acid distribution

Literature Information

Literature 1

Pubmed ID 32126228

Title Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin

Doi 10.1016/j.bbamem.2020.183228

Year 2020

Patent

Patent ID Not available

Patent Title Not available

Other Iinformation Not available

Other Published ID Not available